For example, in xenograft models of cancers such as leukemia and breast cancer, different doses of quercetin inhibit the cell cycle and increase programmed cell death by inhibiting the AKT/mTOR signaling pathway [147, 148]. The gene discussed is AKT1; the disease is cancer.